BioNexus Gene Lab signs exclusive Malaysia CogniAI licence

BioNexus Gene Lab entered a CogniAI Healthcare licence and strategic collaboration agreement for Malaysia, granting rights to develop, brand and sublicense applications, with 560,000 shares to be issued at closing.